| Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study R Pieters, P De Lorenzo, P Ancliffe, LA Aversa, B Brethon, A Biondi, ... Journal of clinical oncology 37 (25), 2246-2256, 2019 | 175 | 2019 |
| Meningiomas in children and adolescents: a meta-analysis of individual patient data RS Kotecha, EM Pascoe, EJ Rushing, LB Rorke-Adams, T Zwerdling, ... The lancet oncology 12 (13), 1229-1239, 2011 | 158 | 2011 |
| Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group NG Gottardo, JR Hansford, JP McGlade, F Alvaro, DM Ashley, S Bailey, ... Acta neuropathologica 127, 189-201, 2014 | 142 | 2014 |
| Challenges posed by COVID-19 to children with cancer RS Kotecha The Lancet Oncology 21 (5), e235, 2020 | 102 | 2020 |
| Pediatric meningioma: current approaches and future direction RS Kotecha, RC Junckerstorff, S Lee, CH Cole, NG Gottardo Journal of neuro-oncology 104, 1-10, 2011 | 84 | 2011 |
| Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL) RS Kotecha, N Powers, SJ Lee, KJ Murray, T Carter, C Cole Pediatric blood & cancer 54 (7), 934-940, 2010 | 75 | 2010 |
| The evolution of clinical trials for infant acute lymphoblastic leukemia RS Kotecha, NG Gottardo, UR Kees, CH Cole Blood cancer journal 4 (4), e200-e200, 2014 | 49 | 2014 |
| Clinical implications of minimal residual disease detection in infants with KMT2A-rearranged acute lymphoblastic leukemia treated on the interfant-06 protocol J Stutterheim, IM van der Sluis, P de Lorenzo, J Alten, P Ancliffe, ... Journal of Clinical Oncology 39 (6), 652, 2021 | 42 | 2021 |
| Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10‐year review AW Bartlett, MP Cann, DK Yeoh, A Bernard, AL Ryan, CC Blyth, ... Pediatric Blood & Cancer 66 (4), e27564, 2019 | 41 | 2019 |
| Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome AP Laurent, RS Kotecha, S Malinge Leukemia 34 (8), 1984-1999, 2020 | 40 | 2020 |
| Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003‐2013 SS Wang, RS Kotecha, A Bernard, CC Blyth, BJ McMullan, MP Cann, ... Pediatric Blood & Cancer 66 (10), e27915, 2019 | 40 | 2019 |
| New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment LC Cheung, J Tickner, AM Hughes, P Skut, M Howlett, B Foley, ... Leukemia 32 (11), 2326-2338, 2018 | 36 | 2018 |
| Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin MN Cruickshank, J Ford, LC Cheung, J Heng, S Singh, J Wells, TW Failes, ... Leukemia 31 (1), 40-50, 2017 | 32 | 2017 |
| Immunogenicity and safety of single‐dose, 13‐valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients TY Hung, RS Kotecha, CC Blyth, SK Steed, RB Thornton, AL Ryan, ... Cancer 123 (21), 4215-4223, 2017 | 31 | 2017 |
| Targeting cytokine-and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma R De Smedt, J Morscio, L Reunes, J Roels, V Bardelli, B Lintermans, ... Blood, The Journal of the American Society of Hematology 135 (19), 1685-1695, 2020 | 30 | 2020 |
| Childhood craniopharyngioma: 20‐year institutional experience in W estern A ustralia SR Rath, S Lee, RS Kotecha, M Taylor, RC Junckerstorff, CSY Choong Journal of Paediatrics and Child Health 49 (5), 403-408, 2013 | 29 | 2013 |
| Morbidity in survivors of child and adolescent meningioma RS Kotecha, P Jacoby, CH Cole, NG Gottardo Cancer 119 (24), 4350-4357, 2013 | 28 | 2013 |
| Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer RS Kotecha, UD Wadia, P Jacoby, AL Ryan, CC Blyth, AD Keil, ... Cancer medicine 5 (2), 285-293, 2016 | 27 | 2016 |
| Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma—An aggressive and fatal disease A Stirnweiss, J Oommen, RS Kotecha, UR Kees, AH Beesley Oncotarget 8 (68), 112313, 2017 | 26 | 2017 |
| RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia F Matthijssens, ND Sharma, M Nysus, CK Nickl, H Kang, DR Perez, ... The Journal of clinical investigation 131 (6), 2021 | 22 | 2021 |
